Original Full Length ArticleSecular trends in the incidence of primary hyperparathyroidism over five decades (1965–2010)☆
Graphical abstract
Introduction
Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder and the most common cause of hypercalcemia in the outpatient setting [1], [2]. We observed a significant increase in PHPT incidence among Rochester, Minnesota residents in 1974 that was associated with the introduction of automated serum chemistry panels and attributed to the identification of previously unrecognized prevalent cases of PHPT with asymptomatic hypercalcemia [3]. After the initial rise in PHPT diagnoses, the incidence fell to 27.7 per 100,000 person-years, which was thought to represent the true rate in an environment of automated measurement of serum calcium [3]. PHPT clinical characteristics also changed in the era of routine calcium measurement, from symptomatic disease with more severe hypercalcemia to asymptomatic PHPT with mild hypercalcemia that was more common in older women who are also at risk for osteoporosis [1], [2], [3], [4], [5], [6], [7].
Throughout the 1980s, the incidence of PHPT in Rochester steadily decreased, and this lower rate persisted throughout most of the 1990s [7], [8]. However, a second sharp increase in PHPT incidence was noted in 1998, which suggested that another important change in the epidemiology of PHPT might be occurring. Furthermore, three recent studies have suggested that the incidence of PHPT was higher than previously reported [4], [5], [9]. The goal of the current study was to update our population-based secular trends in PHPT incidence, to determine if there has been a significant rise in PHPT incidence as suggested by recent investigations, and, if possible, to identify changes in clinical practice that might be responsible. Availability of the population-based medical records-linkage system of the Rochester Epidemiology Project offered a unique opportunity to address this issue [10], [11].
Section snippets
Methods
Most endocrinologic care in this community is provided by the Mayo Clinic, which has maintained a common medical record with its two hospitals for over 100 years. The diagnoses and surgical procedures recorded in these records are indexed, as are the medical records of the other providers who serve the local population [11]. After the approval from the Institutional Review Boards of Mayo Clinic and the Olmsted Medical Center, we used this comprehensive medical records-linkage system (the
Results
Altogether, 341 Rochester residents (269 females, 72 males) were newly diagnosed with PHPT in 2002 through 2010 for a cohort total of 1142 PHPT patients from 1965 through 2010, of whom the majority had definite PHPT (94%). As shown in Fig. 1, however, two periods of increased PHPT incidence occurred, one beginning in 1974 (121.7 per 100,000 person-years, 95% CI: 88.4–154.9, re-adjusted to the 2010 U.S. white population) associated with the introduction of automated serum calcium measurement
Discussion
We have identified a second sharp rise in the incidence of PHPT in Rochester in 1998 similar to that observed in 1974 after the introduction of automated chemistry panels [3]. The first peak in PHPT incidence was attributed to “sweeping” the population for previously unrecognized PHPT cases through routine serum calcium testing. However, the most recent increase occurred despite a reduction in serum calcium measurements (Fig. 2) that accompanied a regulatory change on June 13, 1996, that
Conclusions
The epidemiology of PHPT has exhibited significant changes over the last 5 decades, which appear to largely reflect alterations in medical practice. Clinical medicine is dynamic, with constant innovations in patient care, introduction of new medications and treatment guidelines, and variations in reimbursement paradigms. The clinical spectrum of PHPT first shifted from a symptomatic disease with multiple complications to uncomplicated, asymptomatic PHPT in older individuals with the advent of
Conflict of interest
All authors state that they have no conflicts of interest.
The following are the supplementary data related to this article
Acknowledgments
The authors thank Mary G. Roberts for the help in preparing the manuscript as well as Philip I. Haigh, MD, MSc, FRCSC, FACS from Kaiser Permanente Los Angeles Medical Center and Dr. Ning Yu from Population Heath Sciences at the University of Dundee for providing the summary data from their respective cohorts to allow comparison of their incidence rates to Rochester, Minnesota.
References (34)
Hyperparathyroidism
Lancet
(2009)- et al.
Primary hyperparathyroidism detected in a health screening. The Tromso study.
J Clin Epidemiol
(2000) - et al.
History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population
Mayo Clin Proc
(2012) - et al.
Calcium intake in the United States from dietary and supplemental sources across adult age groups: new estimates from the National Health and Nutrition Examination Survey 2003–2006
J Am Diet Assoc
(2011) - et al.
Estimation of total usual calcium and vitamin D intakes in the United States
J Nutr
(2010) The epidemiology of primary hyperparathyroidism in North America
J Bone Miner Res
(2002)- et al.
Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community
N Engl J Med
(1980) - et al.
Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK
Clin Endocrinol
(2009) - et al.
Increasing incidence of primary hyperparathyroidism in Denmark
Dallas Med J
(2013) - et al.
The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992
Ann Intern Med
(1997)
Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease
J Bone Miner Res
Incidence and prevalence of primary hyperparathyroidism in a racially mixed population
J Clin Endocrinol Metab
Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system
Int J Epidemiol
Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project
Am J Epidemiol
National trends in osteoporosis visits and osteoporosis treatment, 1988–2003
Arch Intern Med
Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women
J Clin Endocrinol Metab
Physician's guide to prevention and treatment of osteoporosis
Cited by (99)
A surgical patient's perspective
2023, American Journal of SurgeryPediatric primary hyperparathyroidism: Surgical pathology and long-term outcomes in sporadic and familial cases
2023, American Journal of SurgeryParathyroidectomy in the elderly is beneficial and safe with similar improvements in postoperative bone mineral density
2022, American Journal of Surgery
- ☆
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging (R01AG034676). The content is solely the responsibility of the authors and does not necessarily represent official views of the National Institutes of Health.